Skip to content

Inhibitory Control and Gait Adaptability in Parkinson's Disease

Relationship Between Inhibitory Control and Gait Adaptability During Obstacle Crossing in People With Parkinson's Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07494461
Enrollment
50
Registered
2026-03-27
Start date
2026-04-01
Completion date
2029-08-31
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease (PD)

Keywords

Electroencephalography, Executive function, Obstacle crossing

Brief summary

People with Parkinson's disease (PD) may have difficulty stopping or changing their movements, especially when walking around obstacles. The goal of this observational study is to learn if a specific cognitive function, called inhibitory control (the ability to stop or control actions) is associated with gait adaptability in people with Parkinson's disease. Gait adaptability means the ability to adjust how a person walks in response to changes in the environment, such as stepping over obstacles. The main questions the study aims to answer are: * If brain activation related to inhibitory control, measured by EEG, is associated with gait adaptability during obstacle crossing in people with Parkinson's disease? * If behavioral inhibitory control is associated with gait adaptability during obstacle crossing in people with Parkinson's disease? Participants take part in one study visit. During this visit, participants complete simple thinking tests, have their brain activity recorded using EEG, and perform walking tasks that include stepping over obstacles.

Interventions

None listed

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* A clinical diagnosis of idiopathic Parkinson's disease; * Stable use of prescribed antiparkinsonian medication for at least two weeks; * Modified Hoehn and Yahr stage I to III; * Age between 18 and 80 years; * Ability to ambulate independently for at least 30 meters without assistive devices; * A Mini-Mental State Examination (MMSE) score of ≥ 24; * Corrected vision and hearing sufficient to effectively receive external stimuli

Exclusion criteria

* The presence of any neurological, musculoskeletal, or cardiovascular disorders that could affect participation in this study; * The presence of psychiatric disorders that could interfere with the ability to follow instructions or comply with study procedures; * A history of brain surgery, such as deep brain stimulation (DBS)

Design outcomes

Primary

MeasureTime frameDescription
Event-related potential - N21 dayMeasure event-related potential through electroencephalography during the Go/No-go test
Event-related potential - P3001 dayMeasure event-related potential through electroencephalography during the Go/No-go test
Stroop color and word test1 dayRecord numbers of corrected color words which the subject responds within 45 sec
Step width1 dayUsing the GAITRite system to measure step width
Stride length/Step length1 dayUsing the GAITRite system to measure stride length and step length during obstacle crossing
Single support time1 dayUsing the GAITRite system to measure single support time during obstacle crossing
Gait speed1 dayGait speed during obstacle crossing was measured using the GAITRite system. Continuous obstacle-crossing walking performance was assessed using the GaitUp system.
Stride length1 dayUsing the GaitUp system to measure stride length during continuous obstacle-crossing walking.
Swing phase1 dayUsing the GaitUp system to measure swing phase during continuous obstacle-crossing walking.
Swing width1 dayUsing the GaitUp system to measure swing width during continuous obstacle-crossing walking.
Four Square Step Test1 dayThe Four Square Step Test is a test used to assess the ability to step over objects and measures the time in seconds to navigate all four squares.

Countries

Taiwan

Contacts

CONTACTYea-Ru Yang, PhD
yryang@nycu.edu.tw+886228267279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026